![]() |
Name |
4,5-Dihydroblumenol A
|
Molecular Formula | C13H22O3 | |
IUPAC Name* |
(4S,5R)-4-hydroxy-4-[(E,3R)-3-hydroxybut-1-enyl]-3,3,5-trimethylcyclohexan-1-one
|
|
SMILES |
C[C@@H]1CC(=O)CC([C@]1(/C=C/[C@@H](C)O)O)(C)C
|
|
InChI |
InChI=1S/C13H22O3/c1-9-7-11(15)8-12(3,4)13(9,16)6-5-10(2)14/h5-6,9-10,14,16H,7-8H2,1-4H3/b6-5+/t9-,10-,13-/m1/s1
|
|
InChIKey |
IHDJYDVWNNFPHR-CHESLIBASA-N
|
|
Synonyms |
4,5-Dihydroblumenol A; 155418-97-6; 4,5-Dihydroblumel A; 4,5-Dihydroblumenol; starbld0000810; DTXSID001315531; ZINC13333972; (4S)-3,3,5alpha-Trimethyl-4alpha-hydroxy-4-[(1E,3R)-3-hydroxy-1-butenyl]cyclohexan-1-one; (4S,5R)-4-hydroxy-4-[(1E,3R)-3-hydroxybut-1-en-1-yl]-3,3,5-trimethylcyclohexan-1-one; (4S,5R)-4-hydroxy-4-[(E,3R)-3-hydroxybut-1-enyl]-3,3,5-trimethylcyclohexan-1-one
|
|
CAS | 155418-97-6 | |
PubChem CID | 21630916 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 226.31 | ALogp: | 0.9 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 57.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 16 | QED Weighted: | 0.71 |
Caco-2 Permeability: | -4.469 | MDCK Permeability: | 0.00002580 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.103 |
Human Intestinal Absorption (HIA): | 0.021 | 20% Bioavailability (F20%): | 0.02 |
30% Bioavailability (F30%): | 0.006 |
Blood-Brain-Barrier Penetration (BBB): | 0.905 | Plasma Protein Binding (PPB): | 73.32% |
Volume Distribution (VD): | 0.877 | Fu: | 27.58% |
CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.238 |
CYP2C19-inhibitor: | 0.047 | CYP2C19-substrate: | 0.821 |
CYP2C9-inhibitor: | 0.031 | CYP2C9-substrate: | 0.592 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.135 |
CYP3A4-inhibitor: | 0.023 | CYP3A4-substrate: | 0.377 |
Clearance (CL): | 6.157 | Half-life (T1/2): | 0.616 |
hERG Blockers: | 0.029 | Human Hepatotoxicity (H-HT): | 0.365 |
Drug-inuced Liver Injury (DILI): | 0.229 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.845 | Maximum Recommended Daily Dose: | 0.95 |
Skin Sensitization: | 0.224 | Carcinogencity: | 0.064 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.142 |
Respiratory Toxicity: | 0.817 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001538 | ![]() |
0.491 | D0H1QY | ![]() |
0.250 | ||
ENC005116 | ![]() |
0.294 | D0Q6NZ | ![]() |
0.216 | ||
ENC004902 | ![]() |
0.288 | D0I5DS | ![]() |
0.200 | ||
ENC000457 | ![]() |
0.278 | D0G6AB | ![]() |
0.198 | ||
ENC004904 | ![]() |
0.276 | D0F1EX | ![]() |
0.196 | ||
ENC004664 | ![]() |
0.275 | D0P0HT | ![]() |
0.189 | ||
ENC002322 | ![]() |
0.275 | D0U3GL | ![]() |
0.186 | ||
ENC002225 | ![]() |
0.273 | D05VQI | ![]() |
0.185 | ||
ENC001047 | ![]() |
0.263 | D0I2SD | ![]() |
0.185 | ||
ENC004209 | ![]() |
0.257 | D0IT2G | ![]() |
0.184 |